- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-06-01-2020
Pharmaceutical Executive
Pharm Exec's Top 50 Companies 2020
July 09, 2020
Features
40
6
Our 20th annual listing highlights brand surges, new ranking battles, and M&A-sparked upswings, but in the shadow of COVID-19, a peek behind the numbers also tells another story.
Better ESG Communication with Investors
June 12, 2020
Columns
40
6
Guidance addresses struggles in reporting non-financial performance.
Will the Biopharma Leaders Please Take the Stage!
June 12, 2020
Columns
40
6
Now is the time, the world is listening.
Adaptive Leadership Through the Pandemic
June 12, 2020
From the Editor
40
6
A major theme permeating our June issue is pharma's reputation issue and how the COVID-19 crisis should be driving new ways executives lead their companies now-and on the other side.
Delivering Hope in a Pandemic
June 11, 2020
Features
40
6
Pharma is boosting outreach and its image, as the industry faces a defining period in its quest to sway the tide of public perception.
The Specter of Compulsory Licensing Haunts Vaccine Debate
June 11, 2020
Columns
40
6
Industry prospects at mercy of public discourse, policy shifts.
Pivotal Moments: How Leaders Can Prepare for the Unexpected
June 11, 2020
Columns
40
6
Balancing bold and pragmatic approaches during times of crisis.
How to Thank a Physician Post-COVID-19
June 11, 2020
Columns
40
6
The appreciation is nice, but advancing their voice-and acting on their experiences-is what HCPs want the most, reports find.
Spotlight on Science Gives Public New Perspective
June 10, 2020
Features
40
6
As government turns to the pharma industry not just for therapies or a vaccine but for tests and data to evaluate these treatments, people are receiving an education.
Rare Insights: Arndt Rolfs, CENTOGENE
June 10, 2020
Features
40
6
Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.
FDA’s Emergency Use Process Under Scrutiny
June 09, 2020
Columns
40
6
As authorizations skyrocket, review standards face questions.
Accelerating Drug Discovery with Supercomputers
June 09, 2020
Columns
40
6
Their use in COVID-19 fight paves way for future leaps.
Product Launch Strategies: Adapting Approaches in 2020 and Beyond
June 01, 2020
Features
40
6
With new access levers emerging, positioning products will require a shift form the traditional launch playbook.
COVID & Chronic Disease: Meeting the Needs of Vulnerable Patients
June 01, 2020
Features
40
6
Pharma companies are in a unique position to support and educate at-risk populations through patient services hubs.
Pharmaceutical Executive, June 2020 Issue (PDF)
June 01, 2020
Issue PDF
40
6
Click the title above to open the Pharmaceutical Executive June 2020 issue in an interactive PDF format.